This inventor holds 1 USPTO granted patent. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: David Armstrong: Innovator in Pharmaceutical Chemistry
Introduction
David Armstrong is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzenesulfonamide derivatives. His research focuses on the development of compounds that can disrupt proteins and polypeptides, which are crucial in the treatment of various diseases.
Latest Patents
David Armstrong holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes benzenesulfonamide derivatives characterized by a specific formula, which are utilized in pharmaceutical compositions. The compounds are designed to disrupt protein and polypeptide functions, offering potential treatments for diseases linked to these biological molecules. His work emphasizes the importance of fluorinated benzene sulfonamide structures in developing effective therapeutic agents.
Career Highlights
Throughout his career, David has worked with several companies, including 2692372 Ontario, Inc. and Dunad Therapeutics Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development and therapeutic solutions.
Collaborations
David has collaborated with notable professionals in his field, including Siawash Ahmar and Geordon A Frere. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
David Armstrong's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for new treatments and advancements in medical science.